+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Non-Infectious Diseases and Vaccination · Registering as Listener

ICNIDV
📅 11 – 12 Feb 2027 📍 La Massana, Andorra 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Non-Infectious Diseases and Vaccination
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 6 SDG 9

This track will explore the latest research on bacterial infections, including resistance mechanisms and novel therapeutic approaches. Emphasis will be placed on the implications of antibiotic resistance and strategies for effective management.

This session will focus on viral infections, with particular attention to emerging viruses and their impact on public health. Discussions will include vaccination strategies and the role of surveillance in controlling outbreaks.

This track will examine the epidemiology of parasitic infections and current treatment modalities. It will highlight recent advancements in diagnostics and the challenges faced in controlling these diseases.

This session will delve into the pathogenesis of fungal infections and the therapeutic options available. It will also address the growing concern of antifungal resistance and the need for new drug development.

This track will focus on mycobacterial infections, particularly tuberculosis, and the global efforts to combat this disease. Discussions will include vaccine development and innovative treatment strategies.

This session will review the lessons learned from past pandemics, including SARS and influenza outbreaks. It will emphasize the importance of preparedness and rapid response in mitigating the impact of future pandemics.

This track will explore current trends in vaccination, including seasonal vaccines and specific strategies for high-risk populations. It will also discuss the future directions of vaccine research and development.

This session will focus on the modeling of infectious diseases, highlighting the tools and techniques used to predict outbreaks and assess intervention strategies. It will cover both mathematical and computational modeling approaches.

This track will examine the development of inflammatory drugs, including NSAIDs and their role in managing infectious diseases. It will address the challenges of drug efficacy and safety in diverse populations.

This session will investigate mortality patterns in historical populations, focusing on the impact of infectious diseases. It will provide insights into how past epidemics have shaped current public health policies.

This track will address the emergence of new pathogens and the importance of surveillance systems in detecting and responding to these threats. It will highlight collaborative efforts in global health to mitigate risks associated with emerging infectious diseases.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED